id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0002-0095,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor's Name and Address; Corrections,Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:39:40Z,2011-6795,0,0,0900006480c0f8fd
FDA-2010-N-0002-0097,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of  New Animal Drug Applications; Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran; Roxarsone; Correction",Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:46:28Z,2011-6790,0,0,0900006480c0fd1e
FDA-2010-N-0002-0096,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Florfenicol; Correction,Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:42:25Z,2011-6789,0,0,0900006480c0fd16
FDA-2010-N-0002-0098,FDA,FDA-2010-N-0002,Certain Other Dosage Form New Animal Drugs: Detomidine; Correction,Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:48:54Z,2011-06791,0,0,0900006480c0fd2a
FDA-2010-N-0002-0094,FDA,FDA-2010-N-0002,Freedom of Information - NADA 141-312 - Labeling,Supporting & Related Material,FOIS-Freedom of Information Summary,2011-01-21T05:00:00Z,2011,1,,,2011-01-21T15:18:02Z,,0,0,0900006480bcfc71
FDA-2010-N-0002-0093,FDA,FDA-2010-N-0002,Freedom Of Information Summary - NADA 141-312 - HEXASOL Injection Oxytetracycline and Flunixin Meglumine Injectable Solution Beef and Non-Lactating Dairy Cattle,Supporting & Related Material,FOIS-Freedom of Information Summary,2011-01-20T05:00:00Z,2011,1,,,2011-01-20T14:24:04Z,,0,0,0900006480bce7ff
FDA-2010-N-0002-0092,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Oxytetracycline and Flunixin,Rule,NFR-Notice of Final Rule,2011-01-20T05:00:00Z,2011,1,2011-01-20T05:00:00Z,,2011-01-20T14:05:26Z,2011-01040,0,0,0900006480bce9e7
FDA-2010-N-0002-0091,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2011-01-18T05:00:00Z,2011,1,2011-01-18T05:00:00Z,,2011-01-18T14:54:02Z,2011-904,0,0,0900006480bcce2d
FDA-2010-N-0002-0090,FDA,FDA-2010-N-0002,New Animal Drugs: Follicle Stimulating Hormone; Change of Sponsor,Rule,NFR-Notice of Final Rule,2011-01-18T05:00:00Z,2011,1,2011-01-18T05:00:00Z,,2011-01-18T14:51:10Z,2011-909,0,0,0900006480bccd28
FDA-2010-N-0002-0088,FDA,FDA-2010-N-0002,New Animal Drugs: Deslorelin,Rule,NFR-Notice of Final Rule,2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2010-12-28T15:43:43Z,2010-32554,0,0,0900006480bc0c09
FDA-2010-N-0002-0089,FDA,FDA-2010-N-0002,Freedom of Information Summary - [NADA-141-319] - Deslorelin acetate Injection Horses/Estrous mares,Other,FOIS-Freedom of Information Summary (No Federal Register Publication),2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2010-12-28T16:01:31Z,,0,0,0900006480bc13dc
FDA-2010-N-0002-0087,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsor's Address,Rule,NFR-Notice of Final Rule,2010-12-21T05:00:00Z,2010,12,2010-12-21T05:00:00Z,,2010-12-21T14:31:22Z,2010-31952,0,0,0900006480bbcc1e
FDA-2010-N-0002-0085,FDA,FDA-2010-N-0002,New Animal Drugs: Mupirocin,Rule,NFR-Notice of Final Rule,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T14:51:05Z,2010-31870,0,0,0900006480bba052
FDA-2010-N-0002-0086,FDA,FDA-2010-N-0002,Freedom of Information Summary - [ANADA-200-457],Supporting & Related Material,FOIS-Freedom of Information Summary,2010-12-20T05:00:00Z,2010,12,,,2010-12-20T15:04:13Z,,0,0,0900006480bba73b
FDA-2010-N-0002-0082,FDA,FDA-2010-N-0002,Freedom of Information Summary [ANADA 200-473 Pharmasin Soluble (tylosin tartrate)],Supporting & Related Material,FOIS-Freedom of Information Summary,2010-12-08T05:00:00Z,2010,12,,,2010-12-08T15:55:03Z,,0,0,0900006480bb1b46
FDA-2010-N-0002-0081,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Tylosin,Rule,NFR-Notice of Final Rule,2010-12-08T05:00:00Z,2010,12,2010-12-08T05:00:00Z,,2010-12-08T15:43:21Z,2010-30814,0,0,0900006480bb1e23
FDA-2010-N-0002-0084,FDA,FDA-2010-N-0002,Freedom of Information Summary [ANADA 200-061- FLU-NIX (flunixin meglumine) Injectable Solution)],Supporting & Related Material,FOIS-Freedom of Information Summary,2010-12-08T05:00:00Z,2010,12,,,2010-12-08T16:26:07Z,,0,0,0900006480bb1b67
FDA-2010-N-0002-0083,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Flunixin,Rule,NFR-Notice of Final Rule,2010-12-08T05:00:00Z,2010,12,2010-12-08T05:00:00Z,,2010-12-08T16:18:02Z,2010-30769,0,0,0900006480bb1ea7
FDA-2010-N-0002-0080,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor's Name and Address,Rule,NFR-Notice of Final Rule,2010-11-26T05:00:00Z,2010,11,2010-11-26T05:00:00Z,,2024-11-07T22:30:37Z,2010-29693,1,0,0900006480ba43cf
FDA-2010-N-0002-0079,FDA,FDA-2010-N-0002,Intramammary Dosage Form New Animal Drugs: Cloxacillin Benzathine,Rule,NFR-Notice of Final Rule,2010-11-22T05:00:00Z,2010,11,2010-11-22T05:00:00Z,,2024-11-07T22:25:26Z,2010-29326,1,0,0900006480ba0922
FDA-2010-N-0002-0078,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsor: Sulfadiazine and Pyrimethamine Suspension,Rule,NFR-Notice of Final Rule,2010-11-15T05:00:00Z,2010,11,,,2010-11-15T17:45:37Z,2010-28549,0,0,0900006480b88cdb
FDA-2010-N-0002-0077,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsors Name,Rule,CEP-Certificate Extending Patent Term,2010-11-10T05:00:00Z,2010,11,2010-11-10T05:00:00Z,,2010-11-10T15:57:56Z,2010-28307,0,0,0900006480b86258
FDA-2010-N-0002-0075,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Domperidone,Rule,NFR-Notice of Final Rule,2010-11-01T04:00:00Z,2010,11,,,2010-11-01T15:15:29Z,2010-27524,0,0,0900006480b7c883
FDA-2010-N-0002-0076,FDA,FDA-2010-N-0002,Freedom of Information Summary - EQUIDONE Gel [NADA-141-314] Domperidone,Supporting & Related Material,FOIS-Freedom of Information Summary,2010-11-01T04:00:00Z,2010,11,,,2010-11-01T16:05:49Z,,0,0,0900006480b7d0ab
FDA-2010-N-0002-0074,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor; Monensin Blocks,Rule,NFR-Notice of Final Rule,2010-10-28T04:00:00Z,2010,10,,,2010-10-28T15:36:14Z,2010-27287,0,0,0900006480b79676
FDA-2010-N-0002-0073,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran",Rule,NFR-Notice of Final Rule,2010-10-26T04:00:00Z,2010,10,,,2010-10-26T14:48:15Z,2010-27011,0,0,0900006480b7753a
FDA-2010-N-0002-0071,FDA,FDA-2010-N-0002,Certain Other Dosage Form New Animal Drugs: Progesterone Intravaginal Inserts,Rule,NFR-Notice of Final Rule,2010-10-14T04:00:00Z,2010,10,,,2010-10-14T17:22:27Z,2010-25893,0,0,0900006480b6eed0
FDA-2010-N-0002-0072,FDA,FDA-2010-N-0002,Progesterone NADA 141-200 - Freedom of Information Summary,Supporting & Related Material,FOIS-Freedom of Information Summary,2010-10-14T04:00:00Z,2010,10,,,2010-10-14T17:39:37Z,,0,0,0900006480b6f3b2
FDA-2010-N-0002-0070,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid,Other,FOIS-Freedom of Information Summary (No Federal Register Publication),2010-10-12T04:00:00Z,2010,10,2010-10-12T04:00:00Z,,2010-10-12T15:38:15Z,,0,0,0900006480b6d1c7
FDA-2010-N-0002-0069,FDA,FDA-2010-N-0002,Implantation and Injectable Dosage Form New Animal Drugs: Ceftiofur Crystalline Free Acid; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-10-12T04:00:00Z,2010,10,2010-10-12T04:00:00Z,,2010-10-12T15:25:22Z,2010-25527,0,0,0900006480b6c491
FDA-2010-N-0002-0066,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs; Dexmedetomidine,Rule,NFR-Notice of Final Rule,2010-09-30T04:00:00Z,2010,9,2010-09-30T04:00:00Z,,2010-09-30T15:28:17Z,2010-24494,0,0,0900006480b64109
FDA-2010-N-0002-0067,FDA,FDA-2010-N-0002,Freedom of Information Summary [NADA 141-267 Dexdomitor (dexmedetomidine hydrochloride) sterile injectable solution cats],Supporting & Related Material,FOIS-Freedom of Information Summary,2010-09-30T04:00:00Z,2010,9,,,2010-09-30T15:37:30Z,,0,0,0900006480b64614
FDA-2010-N-0002-0068,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds; Melengestrol,Rule,NFR-Notice of Final Rule,2010-09-30T04:00:00Z,2010,9,2010-09-30T04:00:00Z,,2010-09-30T15:42:59Z,2010-24480,0,0,0900006480b64158
FDA-2010-N-0002-0064,FDA,FDA-2010-N-0002,Implantation and Injectable Dosage Form New Animal Drugs: Firocoxib,Rule,NFR-Notice of Final Rule,2010-09-28T04:00:00Z,2010,9,2010-09-28T04:00:00Z,,2010-09-28T14:58:35Z,2010-24254,0,0,0900006480b62263
FDA-2010-N-0002-0065,FDA,FDA-2010-N-0002,Freedom of Information Summary - EQUIOXX Injection [NADA-141-313] Firocoxib,Supporting & Related Material,FOIS-Freedom of Information Summary,2010-09-28T04:00:00Z,2010,9,,,2010-09-28T16:22:04Z,,0,0,0900006480b620ce
FDA-2010-N-0002-0063,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Chloramphenicol; Lincomycin;Pyrantel Tartrate; and Tylosin Phosphate and Sulfamethazine",Rule,NFR-Notice of Final Rule,2010-09-14T04:00:00Z,2010,9,,,2010-09-14T15:22:40Z,2010-22808,0,0,0900006480b4ea9e
FDA-2010-N-0002-0062,FDA,FDA-2010-N-0002,Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Ophthalmic Solution; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-09-08T04:00:00Z,2010,9,2010-09-08T04:00:00Z,,2010-09-09T15:50:59Z,2010-22276,0,0,0900006480b48200
FDA-2010-N-0002-0061,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Tiamulin,Rule,NFR-Notice of Final Rule,2010-09-08T04:00:00Z,2010,9,2010-09-08T04:00:00Z,,2010-09-09T16:00:35Z,2010-22277,0,0,0900006480b481aa
FDA-2010-N-0002-0059,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feed: Ractopamine,Notice,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T15:18:04Z,,0,0,0900006480b44db9
FDA-2010-N-0002-0056,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor's Name and Address,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T14:51:56Z,2010-22044,0,0,0900006480b4490f
FDA-2010-N-0002-0060,FDA,FDA-2010-N-0002,Freedom of Information - [NADA 141-225] - Optaflexx plus Rumensin plus Tylan,Supporting & Related Material,FOIS-Freedom of Information Summary,2010-09-03T04:00:00Z,2010,9,,,2010-09-03T15:21:33Z,,0,0,0900006480b44dbc
FDA-2010-N-0002-0055,FDA,FDA-2010-N-0002,Freedom of Information - [NADA 141-229] - Resflor Gold,Supporting & Related Material,FOIS-Freedom of Information Summary,2010-09-03T04:00:00Z,2010,9,,,2010-09-03T14:48:53Z,,0,0,0900006480b44d3d
FDA-2010-N-0002-0057,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsor: Penicillin G Benzathine and Penicillin G Procaine Suspension; Penicillin G Procaine Aqueous Suspension,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T15:04:07Z,2010-22042,0,0,0900006480b449d2
FDA-2010-N-0002-0053,FDA,FDA-2010-N-0002,Freedom of Information - [NADA 141-224] - Optaflexx plus Rumensin plus Tylan,Supporting & Related Material,FOIS-Freedom of Information Summary,2010-09-03T04:00:00Z,2010,9,,,2010-09-03T14:41:24Z,,0,0,0900006480b44d38
FDA-2010-N-0002-0052,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feed: Ractopamine,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T14:36:56Z,2010-22071,0,0,0900006480b444d4
FDA-2010-N-0002-0054,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Florfenicol and Flunixin,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,,,2010-09-03T14:45:33Z,2010-22039,0,0,0900006480b444ef
FDA-2010-N-0002-0058,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Praziquantel and Pyrantel,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T15:07:38Z,2010-22043,0,0,0900006480b449d4
FDA-2010-N-0002-0051,FDA,FDA-2010-N-0002,New Animal Drugs; Changes of Sponsors; Withdrawals of Approvals of New Animal Drug Applications: Deslorelin Acetate; Dichlorophene and Toluene Capsules; Pyrantel Pamoate Suspension,Rule,CEP-Certificate Extending Patent Term,2010-08-27T04:00:00Z,2010,8,2010-08-27T04:00:00Z,,2010-08-27T13:34:20Z,2010-21296,0,0,0900006480b3c459
FDA-2010-N-0002-0050,FDA,FDA-2010-N-0002,Withdrawals of Approvals of New Animal Drug Applications: Dichlorophene and Toluene Capsules,Notice,NWL-Notice of Withdrawl,2010-08-27T04:00:00Z,2010,8,2010-08-27T04:00:00Z,,2010-08-27T15:03:53Z,2010-21295,0,0,0900006480b3c3b7
FDA-2010-N-0002-0048,FDA,FDA-2010-N-0002,Implantations or Injectable Dosages Form New Animal Drugs: Propofol,Rule,NFR-Notice of Final Rule,2010-07-06T04:00:00Z,2010,7,,,2010-07-06T15:44:47Z,2010-16301,0,0,0900006480b13970
FDA-2010-N-0002-0049,FDA,FDA-2010-N-0002,PROPOCLEAR (propofol) Injectable Cats and Dogs,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2010-07-06T04:00:00Z,2010,7,,,2010-07-06T16:07:53Z,,0,0,0900006480b136d8
FDA-2010-N-0002-0047,FDA,FDA-2010-N-0002,"Penicillin G Procaine Freedom of Information Summary  NADA 065-010, Spnsored by Norbrook Laboratories, Ltd.",Supporting & Related Material,N-Notice (Supporting and Related Material),2010-06-21T04:00:00Z,2010,6,,,2010-10-29T01:10:46Z,,0,0,0900006480b071b4
FDA-2010-N-0002-0046,FDA,FDA-2010-N-0002,Approval of a Supplemental New Animal Drug Application: Penicillin G Procaine Suspension,Notice,N-Notice,2010-06-21T04:00:00Z,2010,6,2010-06-21T04:00:00Z,,2010-10-29T01:10:46Z,2010-14865,0,0,0900006480b06f57
FDA-2010-N-0002-0045,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Florfenicol,Rule,NFR-Notice of Final Rule,2010-06-17T04:00:00Z,2010,6,,,2010-10-29T01:10:45Z,2010-14611,0,0,0900006480b03b6f
FDA-2010-N-0002-0041,FDA,FDA-2010-N-0002,Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution,Rule,NFR-Notice of Final Rule,2010-05-12T04:00:00Z,2010,5,2010-05-12T04:00:00Z,,2010-05-12T13:53:44Z,2010-11244,0,0,0900006480aebea3
FDA-2010-N-0002-0044,FDA,FDA-2010-N-0002,"Freedom of Information (FOI) Summary for  Orbax Oral Suspension (orbifloxacin) NADA 141-305 Sponsored by Intervet, Inc.",Supporting & Related Material,FOIS-Freedom of Information Summary,2010-05-12T04:00:00Z,2010,5,,,2010-05-12T14:31:24Z,,0,0,0900006480aeb8a8
FDA-2010-N-0002-0039,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin,Rule,NFR-Notice of Final Rule,2010-05-12T04:00:00Z,2010,5,2010-05-12T04:00:00Z,,2010-05-12T13:37:48Z,2010-11282,0,0,0900006480aebe42
FDA-2010-N-0002-0043,FDA,FDA-2010-N-0002,Oral Dosages Form New Animal Drugs: Orbifloxacin Suspension,Rule,NFR-Notice of Final Rule,2010-05-12T04:00:00Z,2010,5,2010-05-12T04:00:00Z,,2010-05-12T14:14:28Z,2010-11245,0,0,0900006480aebeee
FDA-2010-N-0002-0042,FDA,FDA-2010-N-0002,"Freedom of Information (FOI) Summary for (Ivermectin) Privermectin ANADA 200-340 Sponsored by First Priority, Inc.",Supporting & Related Material,FOIS-Freedom of Information Summary,2010-05-12T04:00:00Z,2010,5,,,2010-05-12T14:33:59Z,,0,0,0900006480aeb859
FDA-2010-N-0002-0040,FDA,FDA-2010-N-0002,"Freedom of Information (FOI) Summary for Ivermectin Injection ANADA 200-429 Sponsored by Sparhawk Laboratories, Inc.",Supporting & Related Material,FOIS-Freedom of Information Summary,2010-05-12T04:00:00Z,2010,5,,,2010-05-12T13:46:42Z,,0,0,0900006480aeb854
FDA-2010-N-0002-0038,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products: Withdrawal of Approval of a New Animal Drug Application; Buquinolate; Coumaphos",Rule,NFR-Notice of Final Rule,2010-05-05T04:00:00Z,2010,5,2010-05-05T04:00:00Z,,2010-05-05T18:21:18Z,2010-10564,0,0,0900006480ae7219
FDA-2010-N-0002-0037,FDA,FDA-2010-N-0002,Withdrawal of Approval of New Animal Drug Applications: Coumaphos; Novobiocin; Buquinolate and Lincomycin,Notice,NWL-Notice of Withdrawl,2010-05-05T04:00:00Z,2010,5,2010-05-05T04:00:00Z,,2012-09-13T19:32:02Z,2010-10567,0,0,0900006480ae714e
FDA-2010-N-0002-0036,FDA,FDA-2010-N-0002,"Freedom Of Information (FOI) Summary - ANADA 200-446 Butorphine Veterinary Injection (Butorphanol tartrate, USP) Injectable Solution",Supporting & Related Material,FOIS-Freedom of Information Summary,2010-04-29T04:00:00Z,2010,4,,,2010-04-29T14:14:33Z,,0,0,0900006480ae353a
FDA-2010-N-0002-0035,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Butorphanol,Rule,NFR-Notice of Final Rule,2010-04-29T04:00:00Z,2010,4,,,2010-04-29T14:05:53Z,2010-09871,0,0,0900006480ae39a6
FDA-2010-N-0002-0034,FDA,FDA-2010-N-0002,Norocillin Penicillin G Procaine Injectable Suspension (NADA 065-010) - Freedom of Information Summary,Other,FOIS-Freedom of Information Summary (No Federal Register Publication),2010-04-27T04:00:00Z,2010,4,,,2010-04-27T19:56:00Z,,0,0,0900006480ae16d2
FDA-2010-N-0002-0033,FDA,FDA-2010-N-0002,Freedom Of Information Summary - [NADA 141-306 - Dormosed Gel Detomidine hydrochloride Oromucosal Gel Horses - Orion Corporation],Supporting & Related Material,FOIS-Freedom of Information Summary,2010-04-23T04:00:00Z,2010,4,,,2010-04-23T15:17:21Z,,0,0,0900006480ade217
FDA-2010-N-0002-0032,FDA,FDA-2010-N-0002,Certain Other Dosage Form New Animal Drugs; Detomidine,Rule,NFR-Notice of Final Rule,2010-04-23T04:00:00Z,2010,4,,,2010-04-23T15:05:24Z,2010-09371,0,0,0900006480ade6c3
FDA-2010-N-0002-0031,FDA,FDA-2010-N-0002,"Freedom Of Information (FOI) Summary - Heifiermax 500, Optaflexx and Rumensin",Supporting & Related Material,FOIS-Freedom of Information Summary,2010-04-22T04:00:00Z,2010,4,,,2010-04-22T15:25:24Z,,0,0,0900006480add4cd
FDA-2010-N-0002-0030,FDA,FDA-2010-N-0002,"New Animal Drugs for Use in Animal Feeds: Melengestrol, Monensin, and Ractopamine",Rule,NFR-Notice of Final Rule,2010-04-22T04:00:00Z,2010,4,,,2010-04-22T13:40:34Z,2010-09304,0,0,0900006480adcfba
FDA-2010-N-0002-0028,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2010-04-20T04:00:00Z,2010,4,2010-04-20T04:00:00Z,,2024-11-12T04:53:46Z,2010-09057,1,0,0900006480adba4f
FDA-2010-N-0002-0029,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2010-04-20T04:00:00Z,2010,4,2010-04-20T04:00:00Z,,2024-11-12T04:53:58Z,2010-09045,1,0,0900006480adbad7
FDA-2010-N-0002-0027,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Change of Sponsor; Propofol,Rule,NFR-Notice of Final Rule,2010-04-19T04:00:00Z,2010,4,2010-04-19T04:00:00Z,,2024-11-07T22:17:54Z,2010-08945,1,0,0900006480adaf52
FDA-2010-N-0002-0026,FDA,FDA-2010-N-0002,"Freedom Of Information Summary [NADA 141-266] - POSATEX Otic Suspension Orbifloxcin, Mometasone Furate Monohydrate and Posaconazole, Suspenion Dogs",Supporting & Related Material,BKG-Background Material,2010-04-01T04:00:00Z,2010,4,,,2010-04-01T16:12:53Z,,0,0,0900006480acde2d
FDA-2010-N-0002-0025,FDA,FDA-2010-N-0002,"Ophthalmic and Topical Dosage Form New Animal Drugs: Orbifloxacin, Mometasone Furoate Monohydrate, and Posaconazole Suspension",Rule,NFR-Notice of Final Rule,2010-04-01T04:00:00Z,2010,4,,,2010-04-01T16:05:18Z,2010-07163,0,0,0900006480ace19b
FDA-2010-N-0002-0023,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Flunixin,Rule,NFR-Notice of Final Rule,2010-03-19T04:00:00Z,2010,3,,,2010-03-19T14:36:48Z,2010-06038,0,0,0900006480ac18f4
FDA-2010-N-0002-0024,FDA,FDA-2010-N-0002,Freedom Of Information Summary - [ANADA 200-489] - FLUNAZINE-S (flunixin meglumine) Injectable Solution,Supporting & Related Material,FOIS-Freedom of Information Summary,2010-03-19T04:00:00Z,2010,3,,,2010-03-19T14:44:01Z,,0,0,0900006480ac19f7
FDA-2010-N-0002-0022,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Tetracycline Powder; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-03-18T04:00:00Z,2010,3,2010-03-18T04:00:00Z,,2010-03-18T15:23:20Z,2010-05925,0,0,0900006480ac0362
FDA-2010-N-0002-0020,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Zilpaterol,Notice,NFR-Notice of Final Rule,2010-03-11T05:00:00Z,2010,3,2010-03-11T05:00:00Z,,2010-03-11T17:47:38Z,,0,0,0900006480abb716
FDA-2010-N-0002-0021,FDA,FDA-2010-N-0002,Freedom Of Information Summary - [ANADA 200-479] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride),Supporting & Related Material,FOIS-Freedom of Information Summary,2010-03-11T05:00:00Z,2010,3,,,2010-03-11T18:09:07Z,,0,0,0900006480abb71d
FDA-2010-N-0002-0018,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Zilpaterol,Notice,NFR-Notice of Final Rule,2010-03-11T05:00:00Z,2010,3,2010-03-11T05:00:00Z,,2010-03-11T15:56:32Z,,0,0,0900006480abb59e
FDA-2010-N-0002-0019,FDA,FDA-2010-N-0002,Freedom Of Information Summary - [ANADA 200-480] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride),Supporting & Related Material,FOIS-Freedom of Information Summary,2010-03-11T05:00:00Z,2010,3,,,2010-03-11T17:30:03Z,,0,0,0900006480abb5a0
FDA-2010-N-0002-0016,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Zilpaterol,Rule,NFR-Notice of Final Rule,2010-03-11T05:00:00Z,2010,3,,,2010-03-11T15:33:43Z,2010-05224,0,0,0900006480abaf98
FDA-2010-N-0002-0017,FDA,FDA-2010-N-0002,Freedom Of Information Summary - [ANADA 200-483] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride),Supporting & Related Material,BKG-Background Material,2010-03-11T05:00:00Z,2010,3,,,2010-03-11T15:49:58Z,,0,0,0900006480abb097
FDA-2010-N-0002-0014,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2010-03-05T05:00:00Z,2010,3,,,2010-03-09T14:28:56Z,2010-04560,0,0,0900006480ab5f5b
FDA-2010-N-0002-0015,FDA,FDA-2010-N-0002,Freedom of Information Summary Supplement New Animal Drug Application - [NADA 141-251 - Advantage Muti for Dogs - Bayer HealthCare LLC],Supporting & Related Material,FOIS-Freedom of Information Summary,2010-03-05T05:00:00Z,2010,3,,,2010-03-05T19:55:18Z,,0,0,0900006480aaf84e
FDA-2010-N-0002-0012,FDA,FDA-2010-N-0002,Freedom of Information Summary Supplement New Animal Drug Application for Tilmicosin - [NADA 149-929 - Elanco Animal Health],Supporting & Related Material,BKG-Background Material,2010-03-02T05:00:00Z,2010,3,,,2010-03-03T20:30:11Z,,0,0,0900006480ab214b
FDA-2010-N-0002-0013,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds; Chlortetracycline,Notice,NFR-Notice of Final Rule,2010-03-02T05:00:00Z,2010,3,,,2010-03-02T17:55:52Z,2010-04205,0,0,0900006480ab1f1b
FDA-2010-N-0002-0011,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs; Tilmicosin,Notice,NFR-Notice of Final Rule,2010-03-02T05:00:00Z,2010,3,,,2010-03-02T17:35:31Z,2010-04206,0,0,0900006480ab1ea5
FDA-2010-N-0002-0010,FDA,FDA-2010-N-0002,"Bacitracin Zinc and Nicarbazin, ANADA 200-478, Albac 50 plus Nicarb; Freedom of Information (FOI) Summary",Supporting & Related Material,FOIS-Freedom of Information Summary,2010-02-23T05:00:00Z,2010,2,,,2010-02-23T14:39:57Z,,0,0,0900006480aab373
FDA-2010-N-0002-0009,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Bacitracin Zinc; Nicarbazin,Rule,NFR-Notice of Final Rule,2010-02-22T05:00:00Z,2010,2,2010-02-22T05:00:00Z,,2010-02-23T13:57:08Z,2010-03328,0,0,0900006480aa9b3b
FDA-2010-N-0002-0008,FDA,FDA-2010-N-0002,"Freedom of Information Summary - [141-301]- Ractopamine Hydrochloride and Monensin, USP Type A Medicated Arcticles to be used in the Manufacture of Type C Medicated Feeds Finishing Hen and Tom Turkeys",Supporting & Related Material,FOIS-Freedom of Information Summary,2010-02-16T05:00:00Z,2010,2,,,2010-02-17T17:02:48Z,,0,0,0900006480aa5817
FDA-2010-N-0002-0007,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Ractopamine; Monensin,Notice,NFR-Notice of Final Rule,2010-02-05T05:00:00Z,2010,2,2010-02-05T05:00:00Z,,2010-02-17T05:05:20Z,2010-02427,0,0,0900006480a8e9ae
FDA-2010-N-0002-0006,FDA,FDA-2010-N-0002,Labeling of EXCEDE - [ NADA 141-209 - Freedom of Information ],Supporting & Related Material,Freedom of Information Summary,2010-02-03T05:00:00Z,2010,2,,,2014-01-07T21:32:50Z,,0,0,0900006480a8bb21
FDA-2010-N-0002-0005,FDA,FDA-2010-N-0002,Labeling - [ NADA 141-298 - Freedom of Information ]; Surolan,Supporting & Related Material,Freedom of Information Summary,2010-02-03T05:00:00Z,2010,2,,,2014-01-07T21:29:16Z,,0,0,0900006480a8bb1f
FDA-2010-N-0002-0003,FDA,FDA-2010-N-0002,"Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and Prednisolone Suspension",Notice,Notice of Final Rule,2010-01-29T05:00:00Z,2010,1,2010-01-29T05:00:00Z,,2013-07-08T19:24:29Z,2010-01794,0,0,0900006480a870c7
FDA-2010-N-0002-0002,FDA,FDA-2010-N-0002,"EXCEDE Sterile Suspension, Ceftiofur Crystalline Free Acid Horses - Freedom of Information Summary - [NADA-141-209]",Supporting & Related Material,Freedom of Information Summary,2010-01-29T05:00:00Z,2010,1,,,2014-01-07T21:31:43Z,,0,0,0900006480a86f5c
FDA-2010-N-0002-0001,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid,Notice,Notice of Final Rule,2010-01-29T05:00:00Z,2010,1,2010-01-29T05:00:00Z,,2013-07-08T19:48:56Z,2010-01790,0,0,0900006480a87061
FDA-2010-N-0002-0004,FDA,FDA-2010-N-0002,Freedom of Information Summary - [NADA-141-298],Supporting & Related Material,Freedom of Information Summary,2010-01-29T05:00:00Z,2010,1,,,2013-07-08T19:26:42Z,,0,0,0900006480a86f5e